check_circleStudy Completed

Dermatitis, Atopic

Bayer Identifier:

Trial_87105

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Comparison of a twice daily use of methylprednisolone aceponate cream and prednicarbate cream (Dermatop) in children with atopic dermatitis

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

3 - 14 Years
  • -

  • -

Trial summary

Enrollment Goal
79
Trial Dates
October 1987 - May 1988
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Advantan (Methylprednisolone Aceponate, BAY86-4862)
Accepts Healthy Volunteer
N/A

Trial design

Controlled, double-blind group comparison of a twice daily (maximum 3 weeks) use of methylprednisolone aceponate 0.1 % cream (SH C 440 F) and prednicarbate 0.25 % cream (Dermatop) in children with atopic dermatitis
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.